Citation Impact
Citing Papers
Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma
2002
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Defining the role of post-mastectomy radiotherapy: the new evidence.
1996
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
2011
Testicular Germ-Cell Cancer
1997 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Breast cancer
2016 Standout
Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
2002
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)
1991
Pancreatic cancer
2020 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Head and neck cancer
2008 Standout
Gestational trophoblastic disease
2010 Standout
ACR Appropriateness Criteria® on Postmastectomy Radiotherapy
2009
Pancreatic cancer
2016 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
1999
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
2001
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Colorectal cancer
2013 Standout
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
1999
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
2015
Adjuvant radiotherapy in male breast cancer
1999
Pancreatic Adenocarcinoma
2014 Standout
Colorectal cancer
2019 Standout
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
2006
Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology
2003
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Application of Two-Part Statistics for Comparison of Sequence Variant Counts
2011
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
1997
Bladder cancer
2016 Standout
Male breast cancer
2006 Standout
Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma
2001
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Assessment and comparison of prognostic classification schemes for survival data
1999
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Neuroblastoma
2007 Standout
Cannabinoids in medicine: A review of their therapeutic potential
2006
Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
2008
Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
1998
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation
1992
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation
2003
Head and Neck Cancer
2001 Standout
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
1992
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
2009
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000
Role of Cytokine Therapy in 2006 and Beyond for Metastatic Renal Cell Cancer
2006
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Prognostic Factors in Patients with Advanced Renal Cell Carcinoma
2004
Cytokines in Metastatic Renal Cell Carcinoma: Is It Useful to Switch to Interleukin-2 or Interferon After Failure of a First Treatment?
1999
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Sigma Receptors and Cancer
2004
Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors
2004
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
2009
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
2007 Standout
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Cannabinoids for Medical Use
2015 Standout
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911
2007
Predictors of Competing Mortality in Advanced Head and Neck Cancer
2009
Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
2005
Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
2009
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
2012
Study of Failure Pattern Among High-Risk Breast Cancer Patients With or Without Postmastectomy Radiotherapy in Addition to Adjuvant Systemic Therapy: Long-Term Results From the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized Studies
2006
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer
1999
Works of A. Kramar being referenced
Is it useful to remove internal mammary nodes in operable breast cancer?
1987
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial
2014
True
2000
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
2007
Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.
1995
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors
2003
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
2007
Competing risks determining event-free survival in early breast cancer
1992
Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.
1992
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
1996
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
2009
Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimen
1988
Randomised EORTC Head and Neck Cooperative Group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma
1991
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-α
1994
Two-part statistics with paired data
2004
Clinical Significance and Prognostic Value of CA72‐4 Compared with CEA and CA19‐9 in Patients with Gastric Cancer
2000
Reirradiation of head and neck cancers
1985
[Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
1983
Quality-of-life (QOL) assessment after concurrent chemoradiation for invasive bladder cancer. Preliminary results of a French multicenter prospective study
2003
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer
2002
Bayesian Neural Network Models for Censored Data
1997